Schisandrin B has been shown to prevent ischemia-reperfusion injuries in isolated perfused rat hearts by enhancing the glutathione antioxidant response and mitochondrial ATP generation capacity, or by increasing the expression levels of cardiac protective proteins, such as heat shock proteins 25 (HSP25) and HSP70. This evidence concerns the gene HSPB1 and ischemia reperfusion injury.